Reply to “Comment on Effectiveness of a Group B Outer Membrane Vesicle Meningococcal Vaccine in Preventing Hospitalization from Gonorrhea in New Zealand: A Retrospective Cohort Study, Vaccines, 2019, 1, 5; doi:10.3390/vaccines7010005”
Janine Paynter,
Felicity Goodyear-Smith,
Jane Morgan,
Peter Saxton,
Steven Black,
Helen Petousis-Harris
Affiliations
Janine Paynter
Department of General Practice and Primary Health, University of Auckland, Auckland, 1142, New Zealand
Felicity Goodyear-Smith
Department of General Practice and Primary Health, University of Auckland, Auckland, 1142, New Zealand
Jane Morgan
Sexual Health Services Waikato District Health Board and Honorary Senior Lecturer, School of Medicine, University of Auckland, Auckland, 1142, New Zealand
Peter Saxton
Department of Social and Community Health, University of Auckland, Auckland, 1142, New Zealand
Steven Black
Department of Pediatrics, Cincinnati Children’s Hospital, Cincinnati, OH 45229-3039, USA
Helen Petousis-Harris
Immunisation Advisory Centre, Department of General Practice and Primary Health Care, University of Auckland, Auckland, 1142, New Zealand
